US Stock MarketDetailed Quotes

Tarsus Pharmaceuticals (TARS)

Watchlist
  • 72.560
  • +0.135+0.19%
Close Apr 10 16:00 ET
  • 72.560
  • 0.0000.00%
Post 16:10 ET
3.09BMarket Cap-45.64P/E (TTM)

Tarsus Pharmaceuticals (TARS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
85.00%-12.45M
187.14%19.33M
311.01%18.26M
-104.02%-29.39M
45.35%-20.65M
29.33%-83.03M
43.61%-22.18M
73.26%-8.65M
39.55%-14.4M
-72.00%-37.79M
Net income from continuing operations
42.52%-66.42M
63.77%-8.37M
46.26%-12.59M
38.90%-20.34M
29.70%-25.12M
14.97%-115.55M
44.84%-23.11M
40.18%-23.42M
-5.94%-33.29M
-52.57%-35.73M
Operating gains losses
----
----
-233.33%-12K
----
----
1,933.33%2.15M
-91.05%-598K
-93.92%9K
16,786.67%2.53M
509.09%201K
Depreciation and amortization
48.24%1.82M
2.55%443K
61.97%460K
89.54%453K
70.37%460K
39.68%1.23M
24.50%432K
16.39%284K
31.32%239K
159.62%270K
Other non cash items
14.15%1.28M
-0.32%310K
20.61%357K
15.53%305K
23.17%303K
20.63%1.12M
28.51%311K
30.97%296K
16.81%264K
6.03%246K
Change In working capital
280.80%14.64M
337.04%13.58M
144.41%19.33M
-259.53%-16.36M
77.76%-1.91M
1,156.21%3.84M
-104.03%-5.73M
462.85%7.91M
229.12%10.25M
-510.45%-8.59M
-Change in receivables
-28.69%-39.05M
28.06%-12.77M
-2,729.85%-14.1M
651.06%3.91M
-17.94%-16.1M
-114.74%-30.35M
-56.53%-17.76M
108.75%536K
-80.49%521K
-2,152.18%-13.65M
-Change in inventory
14.42%-1.75M
-336.12%-536K
105.67%37K
-68.79%-1.17M
90.96%-84K
34.15%-2.05M
107.34%227K
-4,246.67%-652K
---692K
---929K
-Change in prepaid assets
124.45%1.72M
206.30%8.19M
794.34%7.98M
-3,121.38%-23.17M
719.25%8.73M
-142.96%-7.02M
-313.86%-7.7M
-44.89%-1.15M
255.89%767K
314.40%1.07M
-Change in payables and accrued expense
73.02%8.86M
-44.19%-26.31M
181.83%25.78M
-56.70%3.97M
7.35%5.42M
-58.23%5.12M
-487.68%-18.25M
8.83%9.15M
507.95%9.17M
313.99%5.05M
-Change in other current assets
-192.13%-527K
-807.14%-381K
-1,592.00%-373K
-78.88%102K
17.92%125K
179.67%572K
61.82%-42K
124.51%25K
188.79%483K
178.95%106K
-Change in other current liabilities
20.84%45.39M
20.10%45.39M
--0
--0
--0
322.59%37.56M
325.02%37.79M
--0
96.55%-1K
-2,800.00%-232K
Cash from discontinued investing activities
Operating cash flow
85.00%-12.45M
187.14%19.33M
311.01%18.26M
-104.02%-29.39M
45.35%-20.65M
29.33%-83.03M
43.61%-22.18M
73.26%-8.65M
39.55%-14.4M
-72.00%-37.79M
Investing cash flow
Cash flow from continuing investing activities
78.86%-42.12M
182.71%49.27M
-251.63%-4.74M
-27.59%-51.7M
65.82%-34.94M
-241.67%-199.2M
-433.75%-59.57M
-93.40%3.13M
-163.23%-40.53M
-1,005.12%-102.22M
Net PPE purchase and sale
-529.16%-9.86M
-8,730.56%-6.36M
-577.30%-1.91M
3.66%-1M
-239.08%-590K
-4.33%-1.57M
---72K
24.80%-282K
-32.02%-1.04M
48.82%-174K
Net intangibles purchase and sale
--0
----
----
----
----
-25.00%-5M
---5M
----
----
----
Net investment purchase and sale
83.25%-32.26M
202.07%55.63M
-183.08%-2.83M
-28.41%-50.7M
66.34%-34.35M
-231.84%-192.63M
-405.33%-54.5M
-93.41%3.41M
-160.86%-39.49M
-977.17%-102.05M
Cash from discontinued investing activities
Investing cash flow
78.86%-42.12M
182.71%49.27M
-251.63%-4.74M
-27.59%-51.7M
65.82%-34.94M
-241.67%-199.2M
-433.75%-59.57M
-93.40%3.13M
-163.23%-40.53M
-1,005.12%-102.22M
Financing cash flow
Cash flow from continuing financing activities
-7.29%143.39M
-21.01%2.31M
300.94%2.56M
-95.39%1.95M
25.55%136.56M
18.81%154.66M
-85.19%2.93M
-99.39%639K
8,197.84%42.32M
2,069.78%108.77M
Net issuance payments of debt
--0
--0
--0
----
----
650.00%75M
--0
--0
--75M
--0
Net common stock issuance
37.12%134.77M
--0
--0
96.33%-354K
25.15%135.13M
-17.13%98.29M
--0
-100.04%-43K
---9.64M
--107.97M
Proceeds from stock option exercised by employees
-48.61%8.62M
-21.01%2.31M
-74.60%2.56M
-21.94%2.31M
79.18%1.44M
963.35%16.77M
444.05%2.93M
1,854.65%10.09M
479.22%2.95M
6,069.23%802K
Net other financing activities
----
----
----
----
----
---35.4M
--0
---39K
----
----
Cash from discontinued financing activities
Financing cash flow
-7.29%143.39M
-21.01%2.31M
300.94%2.56M
-95.39%1.95M
25.55%136.56M
18.81%154.66M
-85.19%2.93M
-99.39%639K
8,197.84%42.32M
2,069.78%108.77M
Net cash flow
Beginning cash position
-56.71%97.38M
-34.57%115.29M
-45.22%99.21M
-7.93%178.35M
-56.71%97.38M
213.91%224.95M
-22.26%176.21M
69.61%181.1M
193.51%193.71M
213.91%224.95M
Current changes in cash
169.63%88.82M
189.96%70.92M
429.09%16.08M
-527.59%-79.14M
359.17%80.97M
-183.22%-127.57M
-4,469.80%-78.83M
-104.07%-4.89M
-130.93%-12.61M
-451.69%-31.24M
End cash Position
91.21%186.2M
91.21%186.2M
-34.57%115.29M
-45.22%99.21M
-7.93%178.35M
-56.71%97.38M
-56.71%97.38M
-22.26%176.21M
69.61%181.1M
193.51%193.71M
Free cash flow
75.10%-22.31M
147.60%12.97M
282.98%16.35M
-96.78%-30.39M
44.05%-21.24M
27.16%-89.59M
30.71%-27.25M
75.68%-8.93M
37.26%-15.44M
-70.16%-37.96M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 85.00%-12.45M187.14%19.33M311.01%18.26M-104.02%-29.39M45.35%-20.65M29.33%-83.03M43.61%-22.18M73.26%-8.65M39.55%-14.4M-72.00%-37.79M
Net income from continuing operations 42.52%-66.42M63.77%-8.37M46.26%-12.59M38.90%-20.34M29.70%-25.12M14.97%-115.55M44.84%-23.11M40.18%-23.42M-5.94%-33.29M-52.57%-35.73M
Operating gains losses ---------233.33%-12K--------1,933.33%2.15M-91.05%-598K-93.92%9K16,786.67%2.53M509.09%201K
Depreciation and amortization 48.24%1.82M2.55%443K61.97%460K89.54%453K70.37%460K39.68%1.23M24.50%432K16.39%284K31.32%239K159.62%270K
Other non cash items 14.15%1.28M-0.32%310K20.61%357K15.53%305K23.17%303K20.63%1.12M28.51%311K30.97%296K16.81%264K6.03%246K
Change In working capital 280.80%14.64M337.04%13.58M144.41%19.33M-259.53%-16.36M77.76%-1.91M1,156.21%3.84M-104.03%-5.73M462.85%7.91M229.12%10.25M-510.45%-8.59M
-Change in receivables -28.69%-39.05M28.06%-12.77M-2,729.85%-14.1M651.06%3.91M-17.94%-16.1M-114.74%-30.35M-56.53%-17.76M108.75%536K-80.49%521K-2,152.18%-13.65M
-Change in inventory 14.42%-1.75M-336.12%-536K105.67%37K-68.79%-1.17M90.96%-84K34.15%-2.05M107.34%227K-4,246.67%-652K---692K---929K
-Change in prepaid assets 124.45%1.72M206.30%8.19M794.34%7.98M-3,121.38%-23.17M719.25%8.73M-142.96%-7.02M-313.86%-7.7M-44.89%-1.15M255.89%767K314.40%1.07M
-Change in payables and accrued expense 73.02%8.86M-44.19%-26.31M181.83%25.78M-56.70%3.97M7.35%5.42M-58.23%5.12M-487.68%-18.25M8.83%9.15M507.95%9.17M313.99%5.05M
-Change in other current assets -192.13%-527K-807.14%-381K-1,592.00%-373K-78.88%102K17.92%125K179.67%572K61.82%-42K124.51%25K188.79%483K178.95%106K
-Change in other current liabilities 20.84%45.39M20.10%45.39M--0--0--0322.59%37.56M325.02%37.79M--096.55%-1K-2,800.00%-232K
Cash from discontinued investing activities
Operating cash flow 85.00%-12.45M187.14%19.33M311.01%18.26M-104.02%-29.39M45.35%-20.65M29.33%-83.03M43.61%-22.18M73.26%-8.65M39.55%-14.4M-72.00%-37.79M
Investing cash flow
Cash flow from continuing investing activities 78.86%-42.12M182.71%49.27M-251.63%-4.74M-27.59%-51.7M65.82%-34.94M-241.67%-199.2M-433.75%-59.57M-93.40%3.13M-163.23%-40.53M-1,005.12%-102.22M
Net PPE purchase and sale -529.16%-9.86M-8,730.56%-6.36M-577.30%-1.91M3.66%-1M-239.08%-590K-4.33%-1.57M---72K24.80%-282K-32.02%-1.04M48.82%-174K
Net intangibles purchase and sale --0-----------------25.00%-5M---5M------------
Net investment purchase and sale 83.25%-32.26M202.07%55.63M-183.08%-2.83M-28.41%-50.7M66.34%-34.35M-231.84%-192.63M-405.33%-54.5M-93.41%3.41M-160.86%-39.49M-977.17%-102.05M
Cash from discontinued investing activities
Investing cash flow 78.86%-42.12M182.71%49.27M-251.63%-4.74M-27.59%-51.7M65.82%-34.94M-241.67%-199.2M-433.75%-59.57M-93.40%3.13M-163.23%-40.53M-1,005.12%-102.22M
Financing cash flow
Cash flow from continuing financing activities -7.29%143.39M-21.01%2.31M300.94%2.56M-95.39%1.95M25.55%136.56M18.81%154.66M-85.19%2.93M-99.39%639K8,197.84%42.32M2,069.78%108.77M
Net issuance payments of debt --0--0--0--------650.00%75M--0--0--75M--0
Net common stock issuance 37.12%134.77M--0--096.33%-354K25.15%135.13M-17.13%98.29M--0-100.04%-43K---9.64M--107.97M
Proceeds from stock option exercised by employees -48.61%8.62M-21.01%2.31M-74.60%2.56M-21.94%2.31M79.18%1.44M963.35%16.77M444.05%2.93M1,854.65%10.09M479.22%2.95M6,069.23%802K
Net other financing activities -----------------------35.4M--0---39K--------
Cash from discontinued financing activities
Financing cash flow -7.29%143.39M-21.01%2.31M300.94%2.56M-95.39%1.95M25.55%136.56M18.81%154.66M-85.19%2.93M-99.39%639K8,197.84%42.32M2,069.78%108.77M
Net cash flow
Beginning cash position -56.71%97.38M-34.57%115.29M-45.22%99.21M-7.93%178.35M-56.71%97.38M213.91%224.95M-22.26%176.21M69.61%181.1M193.51%193.71M213.91%224.95M
Current changes in cash 169.63%88.82M189.96%70.92M429.09%16.08M-527.59%-79.14M359.17%80.97M-183.22%-127.57M-4,469.80%-78.83M-104.07%-4.89M-130.93%-12.61M-451.69%-31.24M
End cash Position 91.21%186.2M91.21%186.2M-34.57%115.29M-45.22%99.21M-7.93%178.35M-56.71%97.38M-56.71%97.38M-22.26%176.21M69.61%181.1M193.51%193.71M
Free cash flow 75.10%-22.31M147.60%12.97M282.98%16.35M-96.78%-30.39M44.05%-21.24M27.16%-89.59M30.71%-27.25M75.68%-8.93M37.26%-15.44M-70.16%-37.96M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations Show More